Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
8AM news, hit another wire at 9:13:
Volume continues; now at the ask side. Interesting.
Also interesting is this recent interview with SATT's CEO, Tal Wilk Glazer:
https://medium.com/authority-magazine/life-in-the-worlds-breadbasket-tal-wilk-glazer-of-sativus-tech-on-5-things-you-need-to-create-a-690c65a1fed7
-$
Yes, but there's volume (rare).
By comparing my post's numbers with OTC Market data, updated 3/24, we see that the OS has increased by 21,186 shares, and 330,989 shares which were previously restricted have now become unrestricted.
It's potentially meaningful to compare that OS increase with today's volume.
-$
Down big today....
Fins out. Not much to see, 4.2m o/s so otcmarkets is current:
Market cap: $2,139,136
Unrestricted market cap: $1,414,861
Outstanding Shares 4,194,385
Restricted 1,420,147
Unrestricted 2,774,238
-$
This one will be very interesting if any decent volume hits. It has a good story, and the ss is ludicrous.
-$
$SATT Update: SAFFRON TECH ENTERS STRATEGIC PARTNERSHIP WITH NAVEH PHARMA TO CREATE PREMIUM SAFFRON-BASED COSMETICS AND SUPPLEMENTSPress Release | 03/02/2022
Naveh Pharma currently achieves annual revenues of $1.3m and a net profit of $300,000 and is growing at 30% per year
Joint Venture creates a gateway for Saffron Tech to continue its R&D efforts with the new revenue stream.
Saffron Tech to service pharma companies looking to leverage the natural medicinal properties of saffron in pharmaceutical and nutraceutical applications.
Tel Aviv, Israel, March 02, 2022 (GLOBE NEWSWIRE) -- Sativus Tech Corp (OTC: SATT), an AgTech company that is developing the protocols to grow saffron using vertical farming technology, today announced that its subsidiary, Saffron Tech has signed a non-binding LOI with Naveh Pharma, a company that specializes in creating pharmaceutical and healthcare products with unique active ingredients including saffron. The strategic joint venture is expected to accelerate grown for both companies as the fast-growing nutraceutical industry continues to expand with consumers looking for natural solutions for conditions such as depression and inflammation. The partnership creates undeniable value for both companies and their shareholders by creating a synergy where Saffron Tech would supply Naveh Pharma’s saffron-based supplements.
“This partnership aligns both companies’ unique strengths,” says Tal Wilk Glazer, CEO of Saffron Tech. “Using our premium, lab-grown saffron in nutraceutical and pharmaceutical applications is a testament to the quality of saffron that we are producing. We see significant value in saffron-based supplements, and we look forward to working with Naveh Pharma to unlock the potential of our combined businesses.”
Under the terms of the transaction, Saffron Tech will invest $1.5 million and will hold 70% of the equity of the joint venture. In addition, as part of the agreement, Naveh Pharma will commit to purchase from Saffron Tech, at least 100 kg of saffron extract at over $2,000 a kg which translates to $23,000 per kg of pure saffron.
"I realized long ago that saffron is not just a spice,” says Nitzan Primor, CEO, Naveh Pharma. “Saffron contains ingredients with amazing medicinal properties that could benefit so many if they had access to it. Naveh Pharma and Saffron Tech can leverage their respective research and development data to develop unique and innovative products for the market. The possibility of creating a reliable and pharmaceutical-grade saffron for the world market is a proud milestone for both of our companies.”
The joint venture plans to develop and distribute a line of saffron-based food supplements globally in 2022 and launch a line of saffron-based cosmetics in the second half of 2022. Shared revenues from this joint venture will include existing products already being sold by Naveh Pharma, including a series of seven saffron-based products used for antidepressants, mood support, ADHD and more.
This collaboration could be the first step in a significant increase in the market of saffron-based food supplements and cosmetics supplements.
Completion of the deal is subject to singing a definitive agreement which the Company expenses will occur by the end of March 2022.
About Sativus Tech Corp:
Sativus Tech Corp (OTC: SATT) is an AgTech company that uses advanced vertical farming technology to increase the production of low yield food products in the global marketplace. The company focuses on the research, development, and commercialization of agriculture products that are high in demand but scarce in the marketplace. A reliable supply of these highly coveted food products can be used in various applications including pharmaceutical, nutraceutical, culinary, and the beauty industry. Sativus Tech Corp’s subsidiary, Saffron Tech, is revolutionizing the AgTech world by creating the protocols to grow saffron in indoor vertical farms. It is also increasing the production of the spice by multiplying the number of annual harvests. Sativus Tech Corp’s technology offers a responsible and sustainable way to grow crops in a world confronted by environmental challenges and dwindling earth reserves, diminishing water sources and unstable weather conditions.
Cautionary Note Regarding Forward-Looking Statements
This letter contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks discussed in our Quarterly Reports on Form 10-Q and in our Annual Report on Form 10-K, including in the sections captioned "Risk Factors" and "Forward Looking Statements." Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.
Investor Relations:
Gadi Levin
CEO
(800) 608-6432
Press Inquiries:
info@saffron.ag
Effective Jan. 25,2022 SEDOD will change to SATT:
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
....simply posted a corporate action update. Best o' luck with the stock.
Any thoughts on this thing, or were you simply posting a corporate action update?
It looks legit to me and like this could be a r/s to uplist. They also did have a convertible debt holder with 300k in exercisable warrants at .15 which were to expire in Jan, could be a sweetheart deal for their investor. R/sing from a 40m o/s is a strange move though- clearly not done to reset a bloated float.
Curious whether you're keeping an eye on this. Cheers.
-$
It is getting crushed today.....
SEEDO Corp. changed to Sativus Tech. Corp. and a one for 10 reverse split:
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
SEEDO Corporation (P (SEDO)
0.55 ? 0.0 (0.00%)
Volume: 12,654 @02/17/21 3:56:35 PM EST
Bid Ask Day's Range
0.5 0.56 0.55 - 0.56
SEDO Detailed Quote
SEDO I think We could safely say the Float is probably Bone-Dry
Float 2,500,000 est
https://www.barchart.com/stocks/quotes/SEDO/technical-chart?plot=CANDLE&volume=total&data=WO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=SEDO&grid=1&height=500&studyheight=100
glta
SEEDO Corporation (P (SEDO)
0.55 ? 0.0311 (5.99%)
Volume: 20,590 @02/16/21 3:44:33 PM EST
Bid Ask Day's Range
0.54 0.56 0.54 - 0.70945
SEDO Detailed Quote
SEDO Imo we see a Buck here shortly w/news easy.Very small float.Anything could happen with this one.Fun (: chart glty
https://www.barchart.com/stocks/quotes/SEDO/technical-chart?plot=CANDLE&volume=total&data=WO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=SEDO&grid=1&height=500&studyheight=100
glta
SEEDO Corporation (P (SEDO)
0.461 ? -0.0389 (-7.78%)
Volume: 10,315 @02/02/21 1:48:07 PM EST
Bid Ask Day's Range
0.4622 0.48 0.4601 - 0.5
SEDO Detailed Quote
SEDO hanging this 50 cent line which way does it go (: glty
https://www.barchart.com/stocks/quotes/SEDO/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=SEDO&grid=1&height=500&studyheight=100
SEDO lets see if We can Double Our Fitty cent$ glty
SEEDO Corporation (P (SEDO)
0.45 ? -0.035 (-7.22%)
Volume: 199,105 @01/29/21 11:25:59 AM EST
Bid Ask Day's Range
0.45 0.545 0.45 - 0.5
SEDO Detailed Quote
Good morning Mick, Lets buy some more of Snoops stock (: I think Snoop-Dog is buying ,I am probably crazy ,but we know that already.But i think there is alot coming to this little so so tiny share structure,imo they are up to something Tasty .I am keeping my mailbox in the driveway right here.
SEDO ...continued have a great day and a Green one!
glta
saffron $4900 a pound ,yep, thats what i read I wonder if they are going to do a forward split? there are not many shares lol that would be Sweet as pecan-pie (: SEDO 10 for 12 would be nice not reverse lol
I am adding a few thousand shares for shit$ and giggle$
https://www.barchart.com/stocks/quotes/SEDO/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=SEDO&grid=1&height=500&studyheight=100
glta bra$$ -monkey buy$ (:
SEEDO Corporation (P (SEDO)
0.485 ? 0.125 (34.72%)
Volume: 86,039 @01/28/21 3:42:56 PM EST
Bid Ask Day's Range
0.485 0.5 0.35 - 0.55
SEDO Detailed Quote
First weed now saffron, how cool how north! $SEDO
SEDO .47 interesting they spoke (: hmmmm glty
SEEDO Corporation (P (SEDO)
0.45 ? -0.09 (-16.67%)
Volume: 59,261 @01/26/21 3:47:57 PM EST
Bid Ask Day's Range
0.4 0.45 0.323 - 0.52
SEDO Detailed Quote
SEDO .45 holding well,ready for a POP to a Dollar soon w/News imo
Low float ,to low imo FWD never Straight (: Patience Pays imo
glta
SEDO snoop dog and SEDO what a combo,lol
https://www.barchart.com/stocks/quotes/SEDO/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=SEDO&grid=1&height=500&studyheight=100
glta
I am not buying right now,nobody here seems to be buying SEDO.I wonder who is? lol Spanky ,are You buying? (:
https://www.barchart.com/stocks/quotes/SEDO/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=SEDO&grid=1&height=500&studyheight=100
glta
YES SEEDO Corporation (P (SEDO)
0.36 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
0.35 0.4 - - -
SEDO Detailed Quote
SEDO working towards a buck imo Looking good imo glta
https://www.barchart.com/stocks/quotes/SEDO/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=SEDO&grid=1&height=500&studyheight=100
SEEDO Corporation (P (SEDO)
0.36 ? 0.01 (2.86%)
Volume: 87,149 @01/14/21 3:54:04 PM EST
Bid Ask Day's Range
0.35 0.4 0.3 - 0.428
SEDO Detailed Quote
SEDO .36 looking swell (: glta
I like Your Charts Georgie..very interesting.nice buys .05 .07 sweet.glty Holding my shares for more.there will be much more imo.
low float
https://www.otcmarkets.com/stock/SEDO/profile
glty and have a Great Weekend!
SEDO.30 next week will be a ball.imo more 8-k,s hitting soon imo,low float is actualy to low ,lol fwd split in the works? opinions?
Holding and Adding here Georgie,GL to You and have a Great weekend!
https://www.barchart.com/stocks/quotes/SEDO/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=SEDO&grid=1&height=500&studyheight=100
SEDO...25...on the Upper Bollie Breakout...Psar will flip Bullish tomorrow on the .30 Break...
[5:02 PM]
georgie1812/08/2020
SEDO...12...Breaking the double Top in the .10 range...Looking for a .15 break and a move into the .80 range if we get some consistent volume here...imo...we shall see...Been a long hold with shares mostly in the .05/.075 range...
SEEDO Corporation (P (SEDO)
0.25 ? 0.078 (45.35%)
Volume: 58,616 @01/07/21 3:54:21 PM EST
Bid Ask Day's Range
0.18 0.28 0.18 - 0.25
SEDO Detailed Quote
SEEDO Corporation (P (SEDO)
0.25 ? 0.078 (45.35%)
Volume: 58,616 @01/07/21 3:54:21 PM EST
Bid Ask Day's Range
0.18 0.28 0.18 - 0.25
SEDO Detailed Quote
SEDO...29...on the Upper Bollie Breakout...off my 05/07 range alerts...
SEDO...12...Breaking the double Top in the .10 range...Looking for a .15 break and a move into the .80 range if we get some consistent volume here...imo...we shall see...Been a long hold with shares mostly in the .05/.075 range...
SEDO...25...on the ask here...
SEDO...12...Breaking the double Top in the .10 range...Looking for a .15 break and a move into the .80 range if we get some consistent volume here...imo...we shall see...Been a long hold with shares mostly in the .05/.075 range...
Chart...http://schrts.co/tpKCZSxM
Authorized Shares
500,000,000
11/27/2020
Outstanding Shares
29,502,030
11/27/2020
Restricted
13,477,945
11/27/2020
Unrestricted
16,024,085
11/27/2020
Held at DTC
14,577,422
11/27/2020
SEDO...06...https://www.otcmarkets.com/stock/SEDO/news/story?e&id=1741544 ...
Weird trading today. One part interest, one part dump-a-thon. Anyone have an idea what's up?
-$
Followers
|
12
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
727
|
Created
|
09/18/18
|
Type
|
Free
|
Moderators |
TEL AVIV, Israel and BETHESDA, Maryland, Sept. 18, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that its partner, Eroll Grow Tech (Seedo), has acquired the majority of shares in GRCR partners, which is publicly traded on the OTC market under the symbol GRCR, as announced yesterday.
According to the transaction agreement, Eroll Grow Tech Ltd. (Seedo) will merge its operational activities into GRCR. Cannabics Pharmaceuticals, which provided funds for the transaction, shall eventually receive 13.6% of the merged company, along with a Promissory Note of $350,000 debt owed by Seedo.
"Our involvement with Seedo is continuing to grow. We are glad to see the optimistic responses we are receiving in from both potential partners as well as the media to what we believe will revolutionize personalized medical marijuana," said Eyal Barad, CEO of Cannabics Pharmaceuticals.
"We are also moving ahead with our vision as a part of the platform to build commercialized automated growing platforms to be able to guarantee stable, consistent pharmaceutical grade cannabis worldwide."
"Cannabics Pharmaceuticals will be a very active partner in the development of an automated platform for personalized medical cannabis home grow," Zohar Levy, Seedo's CEO, said: "We thank Cannabics Pharmaceuticals for their trust in our vision and in our company. We have now concluded our pre-order phase and will soon commence delivery."
About Cannabics Pharmaceuticals Inc.
Cannabics Pharmaceuticals Inc. (CNBX) is a U.S public company that has developed a platform which leverages novel drug-screening tools and artificial intelligence to develop cannabinoid-based therapies for cancer that are more precise to a patient's genetic profile. By developing tools to assess effectiveness on a personalized basis, Cannabics is helping to move cannabinoids into the future of cancer therapy. The company's R&D is based in Israel, where it is licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and Cancer.
About Seedo
Seedo is an Israeli company with Subsidiaries in the US and Europe, that developed the world's first fully-automated device managed and controlled by an artificial intelligent algorithm and monitored by smart phone App. Seedo lets consumers grow their own herbs and vegetables in the comfort of their own home, effortlessly. Seedo controls and monitors the growing process, from seed to plant, while providing optimal lab conditions to assure premium quality produce year-round. Company goal is to simplify the growing process, making it accessible for everyone, with no compromising on quality. Visit Seedo at: www.seedolab.com.
HokieHead's Simple Valuation | |||||||
2019 Units Sold | Units Per Month | Units per 50 US States only per month | Projected 2019 Sales | COGS (30%) | OpEx (40%) | Income | PPS with 25 PE |
1,000 | 83 | 20 | $ 2,000,000 | $ 600,000 | $ 800,000 | $ 600,000 | $ 1.00 |
10,000 | 833 | 200 | $ 20,000,000 | $ 6,000,000 | $ 8,000,000 | $ 6,000,000 | $ 10.00 |
25,000 | 2,083 | 500 | $ 50,000,000 | $ 15,000,000 | $ 20,000,000 | $ 15,000,000 | $ 25.00 |
50,000 | 4,167 | 1,000 | $ 100,000,000 | $ 30,000,000 | $ 40,000,000 | $ 30,000,000 | $ 50.00 |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |